{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:25:39Z","timestamp":1793057139262,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ajog.2021.08.060","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T10:44:40Z","timestamp":1631616280000},"page":"347-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1228-9425","authenticated-orcid":false,"given":"Danish","family":"Jaffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preet Mohinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison G.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Palanisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-5244","authenticated-orcid":false,"given":"David Thomas","family":"Monks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.08.060_bib1","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajog.2021.08.060_bib2","doi-asserted-by":"crossref","first-page":"273.e1","DOI":"10.1016\/j.ajog.2009.06.007","article-title":"Effects of onset of labor and mode of delivery on severe postpartum hemorrhage","volume":"201","author":"Al-Zirqi","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib3","first-page":"1","article-title":"Births: final data for 2018","volume":"68","author":"Martin","year":"2019","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2021.08.060_bib5","first-page":"CD011689","article-title":"Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis","volume":"12","author":"Gallos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2021.08.060_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/reprod\/120.1.91","article-title":"Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour","volume":"120","author":"Phaneuf","year":"2000","journal-title":"Reproduction"},{"key":"10.1016\/j.ajog.2021.08.060_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1067\/mob.2003.22","article-title":"Oxytocin-induced desensitization of the oxytocin receptor","volume":"188","author":"Robinson","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/anae.14757","article-title":"International consensus statement on the use of uterotonic agents during caesarean section","volume":"74","author":"Heesen","year":"2019","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ajog.2021.08.060_bib10","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items\u00a0for\u00a0systematic reviews and meta-analyses: the\u00a0PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2021.08.060_bib11","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2021.08.060_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ajog.2021.08.060_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115065","article-title":"Network meta-analysis using R: a review of currently available automated packages","volume":"9","author":"Neupane","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2021.08.060_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.21608\/ebwhj.2018.6218","article-title":"Carbetocin versus oxytocin and ergometrine for prevention of postpartum hemorrhage following caesarean section","volume":"0","author":"Zein El Abdeen","year":"2018","journal-title":"Evid Based Womens Health"},{"key":"10.1016\/j.ajog.2021.08.060_bib15","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.18203\/2320-1770.ijrcog20191238","article-title":"Intrauterine misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss: a randomised clinical trial","volume":"8","author":"Abdelaleem","year":"2019","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4103\/mmj.mmj_160_18","article-title":"Comparison of the effect of carbetocin versus oxytocin during cesarean section in women with high risk of postpartum hemorrhage","volume":"32","author":"Abdelhamid","year":"2019","journal-title":"Menoufia Med J"},{"key":"10.1016\/j.ajog.2021.08.060_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1034\/j.1600-0412.2001.080003245.x","article-title":"A\u00a0randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section","volume":"80","author":"Acharya","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2021.08.060_bib18","first-page":"294","article-title":"Effect of pre-operative sub-lingual misoprostol versus intravenous oxytocin on caesarean operation blood loss","volume":"89","author":"Adefuye","year":"2012","journal-title":"East Afr Med J"},{"key":"10.1016\/j.ajog.2021.08.060_bib19","first-page":"360","article-title":"Postpartum hemorrhage; comparison of efficacy of ergometrine with misoprostol in prophylaxis in cesarean section","volume":"19","author":"Ali","year":"2012","journal-title":"Prof Med J"},{"key":"10.1016\/j.ajog.2021.08.060_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5455\/2320-1770.ijrcog20140909","article-title":"A\u00a0randomized study comparing rectally administered misoprostol after spinal anesthesia versus intramuscular oxytocin for prevention of postpartum hemorrhage in caesarean section","volume":"3","author":"Alwani","year":"2014","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00404-012-2671-1","article-title":"Comparison the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia","volume":"287","author":"Anvaripour","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2021.08.060_bib22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1471-0528.2010.02585.x","article-title":"Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial","volume":"117","author":"Attilakos","year":"2010","journal-title":"BJOG"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2021.08.060_bib23","first-page":"185","article-title":"The safety and efficacy of carbetocin to control uterine bleeding following caesarean section","volume":"1","author":"Barton","year":"1996","journal-title":"Prenat Neonatal Med"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2021.08.060_bib24","first-page":"258","article-title":"Sublingual misoprostol versus oxitocin infusion to reduce blood loss in caesarean section","volume":"122","author":"Begum","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2021.08.060_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00404-009-0973-8","article-title":"Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial","volume":"280","author":"Borruto","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2021.08.060_bib26","first-page":"202","article-title":"Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section","volume":"18","author":"Boucher","year":"1998","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.ajog.2021.08.060_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijgo.2009.11.009","article-title":"Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss","volume":"109","author":"Chaudhuri","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2021.08.060_bib28","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0002-9378(94)90160-0","article-title":"A\u00a0prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2\u03b1, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section","volume":"171","author":"Chou","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(99)70271-1","article-title":"Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section","volume":"180","author":"Dansereau","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/01443610903061744","article-title":"The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section","volume":"29","author":"Eftekhari","year":"2009","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3109\/14767058.2015.1043882","article-title":"Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery","volume":"29","author":"El Behery","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.08.060_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijgo.2016.01.025","article-title":"Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery","volume":"134","author":"Elbohoty","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2021.08.060_bib33","first-page":"79","article-title":"Oxytocin infusion after oxytocin bolus and carbetocin bolus to reduce blood loss during and after cesarean section\u2014a randomized clinical trial","volume":"83","author":"Fahmy","year":"2015","journal-title":"Med J Cairo Univ"},{"key":"10.1016\/j.ajog.2021.08.060_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.egja.2015.09.012","article-title":"Comparative study between effect of carbetocin and oxytocin on isoflurane-induced uterine hypotonia in twin pregnancy patients undergoing cesarean section","volume":"32","author":"Fahmy","year":"2016","journal-title":"Egypt J Anaesth"},{"key":"10.1016\/j.ajog.2021.08.060_bib35","first-page":"41","article-title":"A\u00a0comparison of rectal misoprostol and intravenous oxytocin on hemorrhage and homeostatic changes during cesarean section","volume":"22","author":"Fazel","year":"2013","journal-title":"Middle East J Anaesthesiol"},{"key":"10.1016\/j.ajog.2021.08.060_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3109\/14767058.2015.1011115","article-title":"Sublingual misoprostol is as effective as intravenous oxytocin to reduce intra-operative blood loss during cesarean delivery in women living at high altitude","volume":"29","author":"Gavilanes","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.08.060_bib37","first-page":"1","article-title":"Double-blind randomized comparison of carbetocin versus oxytocin for decrease blood loss from cesarean section in low-risk uterine atony","volume":"4","author":"Jenkumwong","year":"2017","journal-title":"J\u00a0Preg Child Health"},{"key":"10.1016\/j.ajog.2021.08.060_bib38","first-page":"590","article-title":"[Effects of Methylergometrine and oxytocin on blood loss and uterine contraction during cesarean section]","volume":"55","author":"Kikutani","year":"2006","journal-title":"Masui"},{"key":"10.1016\/j.ajog.2021.08.060_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0090-6980(01)00154-X","article-title":"A\u00a0prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage","volume":"66","author":"Lamont","year":"2001","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.ajog.2021.08.060_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1479-828X.2001.tb01319.x","article-title":"Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon","volume":"41","author":"Lokugamage","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1080\/14767058.2016.1192601","article-title":"Carbetocin versus syntometrine for prevention of postpartum hemorrhage after cesarean section","volume":"30","author":"Mohamed Maged","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.08.060_bib42","first-page":"1374150","article-title":"Adverse effects of carbetocin versus oxytocin in the prevention of postpartum haemorrhage after caesarean Section: a randomized controlled trial","volume":"2018","author":"Mannaerts","year":"2018","journal-title":"J\u00a0Preg"},{"key":"10.1016\/j.ajog.2021.08.060_bib43","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1471-0528.2011.03022.x","article-title":"Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial","volume":"118","author":"Moertl","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2021.08.060_bib44","first-page":"167","article-title":"Comparative study between intravenous bolus dose of carbetocin versus oxytocin during cesarean delivery in healthy parturients on blood loss: a randomized control trial","volume":"83","author":"Mohamed","year":"2015","journal-title":"Med J Cairu Univ"},{"key":"10.1016\/j.ajog.2021.08.060_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.redar.2012.06.013","article-title":"Clinical and pharmacological study of the efficacy of carbetocin in elective caesareans compared to low and usual doses of oxytocin","volume":"60","author":"Ortiz-G\u00f3mez","year":"2013","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"10.1016\/j.ajog.2021.08.060_bib46","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.tjog.2016.02.019","article-title":"Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: a randomized clinical trial","volume":"55","author":"Othman","year":"2016","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib47","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1447-0756.2010.01399.x","article-title":"Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial","volume":"37","author":"Owonikoko","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2021.08.060_bib48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s13224-014-0607-3","article-title":"The effect of combined oxytocin\u2013misoprostol versus oxytocin and misoprostol alone in reducing blood loss at Cesarean delivery: a prospective randomized double-blind study","volume":"65","author":"Pakniat","year":"2015","journal-title":"J\u00a0Obstet Gynaecol India"},{"key":"10.1016\/j.ajog.2021.08.060_bib49","first-page":"1053","article-title":"Cardiovascular effects of oxytocin and carbetocin at caesarean section, a prospective double-blind randomised study using non-invasive pulse wave analysis","volume":"61","author":"Rabow","year":"2017","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.ajog.2021.08.060_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejogrb.2015.12.017","article-title":"Carbetocin compared to oxytocin in emergency cesarean section: a randomized trial","volume":"198","author":"Razali","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2021.08.060_bib51","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/ALN.0b013e31829416dd","article-title":"Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo","volume":"119","author":"Rosseland","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ajog.2021.08.060_bib52","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00404-013-2896-7","article-title":"Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study","volume":"288","author":"Elgafor el Sharkwy","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2021.08.060_bib53","first-page":"28","article-title":"Carbetocin versus oxytocin in the active management of third stage of labour following caesarean section: an open label randomised control trial [IO052]","volume":"124","author":"Farhad Siddiqua","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2021.08.060_bib54","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1080\/14767058.2017.1355907","article-title":"Efficacy of oxytocin versus carbetocin in prevention of postpartum hemorrhage after cesarean section under general anesthesia: a prospective randomized clinical trial","volume":"31","author":"Taheripanah","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.08.060_bib55","first-page":"71","article-title":"Carbetocin versus oxytocin for the prevention of\u00a0postpartum hemorrhage following elective cesarean section: Rizal Medical Center experience","volume":"37","author":"Uy","year":"2013","journal-title":"Philipp J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijgo.2005.10.008","article-title":"Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section","volume":"92","author":"Vimala","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2021.08.060_bib57","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.3109\/14767058.2016.1149564","article-title":"Carbetocin versus oxytocin to reduce additional uterotonic use at non-elective caesarean section: a double-blind, randomised trial (.)","volume":"29","author":"Whigham","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.08.060_bib58","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.18203\/2320-1770.ijrcog20194206","article-title":"A\u00a0randomized controlled trial of sublingual misoprostol\u2014600\u03bcg versus intravenous oxytocin\u201410IU in prevention of post partum hemorrhage during cesarean section","volume":"8","author":"Yaliwal","year":"2019","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijoa.2011.03.004","article-title":"Serum oxytocin concentrations in elective caesarean delivery: a randomized comparison of three infusion regimens","volume":"20","author":"Yamaguchi","year":"2011","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ajog.2021.08.060_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLOS Med"},{"key":"10.1016\/j.ajog.2021.08.060_bib61","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2021.08.060_bib62","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00404-010-1522-1","article-title":"Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study","volume":"283","author":"Al Kadri","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2021.08.060_bib63","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1055\/s-0037-1601382","article-title":"Accuracy of blood loss measurement during cesarean delivery","volume":"7","author":"Doctorvaladan","year":"2017","journal-title":"AJP Rep"},{"key":"10.1016\/j.ajog.2021.08.060_bib64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.AOG.0000142709.04450.bd","article-title":"Oxytocin requirements at elective cesarean delivery: a dose-finding study","volume":"104","author":"Carvalho","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.AOG.0000191529.52596.c0","article-title":"Minimum oxytocin dose requirement after cesarean delivery for labor arrest","volume":"107","author":"Balki","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.08.060_bib66","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12630-013-0082-9","article-title":"Carbetocin at elective cesarean delivery: a sequential allocation trial to determine the minimum effective dose","volume":"61","author":"Khan","year":"2014","journal-title":"Can J Anesth"},{"key":"10.1016\/j.ajog.2021.08.060_bib67","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s12630-015-0375-2","article-title":"Carbetocin at cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose","volume":"62","author":"Nguyen-Lu","year":"2015","journal-title":"Can J Anesth"},{"key":"10.1016\/j.ajog.2021.08.060_bib68","first-page":"CD012754","article-title":"Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis","volume":"11","author":"Parry Smith WRP","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2021.08.060_bib69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/ALN.0000000000000682","article-title":"A\u00a0randomized, double-blinded trial of a \u201crule of threes\u201d algorithm versus continuous infusion of oxytocin during elective cesarean delivery","volume":"123","author":"Kovacheva","year":"2015","journal-title":"Anesthesiology"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293782100973X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293782100973X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:36:32Z","timestamp":1757590592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293782100973X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S000293782100973X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.08.060","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.08.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}